Dr Neil Domigan
Chief Executive Officer
Neil has a Phd from the University of Otago and and an MBA from Massey University. He completed postdoctorate studies at Pasteur Institut in Paris, was a Research Fellow at the Christchurch School of Medicine, and Head of Research and Development at Fernz Corporation. He has held executive roles at Genesis Research and Development Corp Ltd, co-ran a government seed venture capital fund, was a Director at Cranleigh Merchant Bank and merchant banker with Mace Consultants in Asia. He is currently Commercial Manager at the Malaghan Institute of Medical Research and Chief Executive of BioOra Ltd.
John is on the Trust Board of the Malaghan Institute of Medical Research and is Chair of Malcorp Biodiscoveries Limited, a subsidiary of the institute. After obtaining a law degree from Victoria University of Wellington in 1975, John was a Fulbright Scholar to Cornell University in 1979. He is Chair of CropLogic Ltd, Fluent Scientific Ltd and the NZ Sports Hall of Fame and a trustee of the Wanaka Festival of Colour and the NZ Diabetes Foundation. John has been a partner in national law firm Kensington Swan, General Manager of Brierley Investments Limited and was the co-founder of Genesis Research and Development Corporation Limited.
Mike is General Manager of the Malaghan Institute of Medical Research and a Director of BioOra Ltd. He completed a Bachelor of Arts at the University of Bristol, before moving to New Zealand in 2002. In 2011 he completed his Postgraduate Diploma in Business Administration at Victoria University of Wellington.
Tom Tang 汤朝阳
Tom is founder and Chair of Hunan Zhaotai Medical Group. He is on the Executive Committee of All-China Federation of Industry and Commerce and Director of China Glorious Association. A senior economist, Tom has a Master of Business Administration and was named in the Top Ten Innovative Entrepreneurs in Global Hunan Business Chinese Outstanding Entrepreneurs.
Dr Peng Li 李鹏
Peng is co-founder, Vice Chair and Chief Scientist of Hunan Zhaotai Medical Group. After ob Cambridge University graduate, he completed postdoctorate studies at the Sanger Institute in the United Kingdom. He is a Research Fellow and PhD supervisor at the Guangzhou Institute of Biomedicine and Health, and Chinese Academy of Sciences. He
was awarded Outstanding Youth from the National Natural Science Foundation of China and High-tech young talents and is involved in Changsha's plan to introduce urgently needed and strategic talents.